Physiomics (LON:PYC) Hits New 12-Month Low – Should You Sell?

Physiomics Plc (LON:PYCGet Free Report) shares reached a new 52-week low during mid-day trading on Monday . The stock traded as low as GBX 0.25 and last traded at GBX 0.28, with a volume of 1805160 shares traded. The stock had previously closed at GBX 0.26.

Physiomics Stock Up 8.9%

The stock has a 50 day moving average of GBX 0.31 and a 200 day moving average of GBX 0.40. The firm has a market cap of £924,787.45, a price-to-earnings ratio of -1.79 and a beta of 1.69.

About Physiomics

(Get Free Report)

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.

Featured Articles

Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.